Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases

Fig. 2

Comparison of intracranial progression-free survival (PFS) (A) and local tumour control (LTC) (B) for WBRT and WBRT + SIB in lung cancer patients with a graded prognostic assessment (GPA) score ≥ 2 using competing risk analyses. Comparison of intracranial PFS (C) and LTC (D) for WBRT and WBRT + SIB in lung cancer patients with stable extracranial disease (ED) using competing risk analyses. Comparison of intracranial PFS (E) and LTC (F) for WBRT and WBRT + SIB in lung cancer patients with a GPA < 2 using competing risk analyses. Comparison of intracranial PFS (G) and LTC (H) for WBRT and WBRT + SIB in lung cancer patients with active ED using competing risk analyses

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us